Puma Biotechnology PBYI Income Statement (2010-2026)

NASDAQ PBYI
$9.55 +0.14 (+1.49%)
As of: Sep 4, 2026 · 3:59 PM EDT
Reported Financials

Puma Biotechnology Quarterly Income Statement

Periods 63 quarters
Latest Jun 2026

Puma Biotechnology reported revenue of $56.50M and net income of $8.19M for the quarter ended Jun 2026, up 7.8% year over year. This income statement covers 63 quarters of results from Dec 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
46.24M55.36M45.74M59.52M57.10M65.67M52.77M54.57M56.12M72.18M43.77M47.08M80.54M59.08M46.01M52.44M54.48M75.45M44.81M56.50M
Cost of RevenueCost of Rev
10.28M11.89M10.84M14.92M12.49M16.84M13.22M11.86M13.28M24.32M10.73M10.66M29.10M13.92M10.56M12.30M12.17M23.13M10.42M12.47M
Gross Profit
35.97M43.46M34.89M44.60M44.61M48.84M39.56M42.71M42.83M47.85M33.04M36.42M51.45M45.16M35.45M40.13M42.30M52.33M34.39M44.03M
Operating items
Research & DevelopmentR&D
18.84M14.17M15.24M11.97M7.00M13.78M12.71M13.36M11.45M12.87M13.59M13.63M12.55M15.17M13.86M15.45M15.91M16.84M19.80M18.89M
Selling, General & AdministrativeSG&A
26.08M22.46M20.40M20.58M23.96M25.04M22.49M24.46M22.80M20.18M21.75M24.97M16.82M16.62M17.60M18.05M16.82M18.38M18.42M17.55M
Restructuring CostsRestructuring
Other Operating ExpensesOther Opex
10.28M11.89M10.84M14.92M23.75M16.84M13.22M11.86M13.28M24.32M10.73M10.66M29.10M13.92M10.56M12.30M12.17M23.13M10.42M12.47M
Operating ExpensesOpex
55.20M48.52M46.48M47.46M54.71M55.66M48.41M49.68M47.53M57.38M46.06M49.26M58.46M45.71M42.02M45.80M44.90M58.35M48.64M48.92M
Operating IncomeOp. Inc
-8.95M6.83M-0.75M12.06M2.39M10.02M4.37M4.89M8.59M14.80M-2.30M-2.18M22.08M13.37M3.98M6.64M9.57M17.11M-3.83M7.58M
EBIT
-8.95M6.83M-0.75M12.06M2.39M10.02M4.37M4.89M8.59M14.80M-2.30M-2.18M22.08M13.37M3.98M6.64M9.57M17.11M-3.83M7.58M
Non-operating items
Non Operating Interest Expenses
3.12M2.72M2.66M2.70M2.95M3.28M3.31M3.33M3.34M3.35M3.36M3.37M3.10M2.62M2.18M1.84M1.49M1.12M0.73M0.18M
Interest & Investment IncomeInt & Inv Inc
0.01M0.01M0.01M0.07M0.22M0.52M0.54M0.66M0.69M0.72M0.97M1.24M1.28M1.23M1.10M0.96M1.04M0.98M1.00M0.83M
Other Non Operating IncomeOther Non Op Inc.
-8.15M0.05M0.06M0.06M-0.20M-0.04M0.09M0.07M0.64M0.09M0.16M0.35M0.27M0.36M0.41M0.12M0.14M0.13M0.01M
Non Operating IncomeNon Op. Inc.
-35.68M-2.40M-2.62M-2.63M-2.69M-15.33M-2.82M-2.58M-2.58M-1.99M-2.30M-1.97M-1.47M-1.13M-0.72M-0.47M-0.33M0.00M0.40M0.66M
Net income details
EBT
-44.63M4.44M-3.37M9.43M-0.29M-5.31M1.55M2.31M6.01M12.80M-4.59M-4.15M20.61M12.24M3.27M6.17M9.24M17.11M-3.43M8.24M
Tax ProvisionsTaxes
0.04M22.58M0.04M0.06M0.07M0.29M0.15M0.19M0.21M0.54M0.22M0.38M0.29M0.01M0.29M0.31M0.40M0.42M0.33M0.06M
Profit After TaxPAT
-44.67M4.22M-3.40M9.37M-0.36M-5.61M1.40M2.13M5.80M12.27M-4.82M-4.53M20.32M19.30M2.97M5.86M8.84M13.41M-3.80M8.19M
Income from Continuing OperationsIncome (Continuing)
-44.67M-18.14M-3.40M9.37M-0.36M-5.61M1.40M2.13M5.80M12.27M-4.82M-4.53M20.32M12.23M2.97M5.86M8.84M16.68M-3.75M8.19M
Consolidated Net IncomeConsol Net Inc.
-44.67M-18.14M-3.40M9.37M-0.36M-5.61M1.40M2.13M5.80M12.27M-4.82M-4.53M20.32M12.23M2.97M5.86M8.84M16.68M-3.75M8.19M
Income towards Parent CompanyParent Net Inc
-44.67M-18.14M-3.40M9.37M-0.36M-5.61M1.40M2.13M5.80M12.27M-4.82M-4.53M20.32M12.23M2.97M5.86M8.84M16.68M-3.75M8.19M
Net Income towards Common StockholdersNet Income
-44.67M-18.14M-3.40M9.37M-0.36M-5.61M1.40M2.13M5.80M12.27M-4.82M-4.53M20.32M12.23M2.97M5.86M8.84M16.68M-3.75M8.19M
Additional items
EPS (Basic)
-1.09-0.45-0.080.21-0.01-0.130.030.050.120.26-0.10-0.090.410.250.060.120.180.33-0.070.16
EPS (Diluted)
-1.09-0.45-0.080.21-0.01-0.120.030.050.120.26-0.10-0.090.410.250.060.120.170.33-0.070.16
Shares Outstanding
40.81M40.64M42.21M45.06M45.57M44.67M46.64M46.76M47.52M47.13M48.19M48.29M49.01M48.65M49.60M49.70M50.34M50.01M50.85M50.94M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
40.81M40.64M42.21M45.36M45.57M44.93M47.16M47.20M47.82M47.55M48.19M48.29M49.17M49.10M49.91M50.14M50.93M50.65M50.85M52.60M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
40.86M41.18M44.95M45.27M45.61M46.35M46.66M46.95M47.54M47.65M48.21M48.46M49.07M49.11M49.62M49.89M50.38M50.41M50.88M51.10M
EBITDA
-8.95M6.83M-0.75M12.06M2.39M10.02M4.37M4.89M8.59M14.80M-2.30M-2.18M22.08M13.37M3.98M6.64M9.57M17.11M-3.83M7.58M
Interest ExpensesInt Expense
3.12M2.72M2.66M2.70M2.95M3.28M3.31M3.33M3.34M3.35M3.36M3.37M3.10M2.62M2.18M1.84M1.49M1.12M0.73M0.18M
Tax Rate
-0.08%508.95%-1.10%0.60%-22.87%-5.53%9.50%8.08%3.54%4.19%-4.79%-9.11%1.41%0.07%8.97%5.03%4.32%2.48%-9.51%0.68%